May/June 2014

 

In this Issue

The New Face of the Glaucoma Doctor

Technological advances as well as demographic and regulatory changes are transforming how physicians care for patients.

Issue

View the E-Dition

CHIEF MEDICAL EDITOR’S PAGE

Lessons Learned From Aravind

By Steven D. Vold, MD

THE LITERATURE

The Literature

By Joseph Panarelli, MD, and Lauren Blieden, MD

CLINICIAN SCIENTIST’S CORNER

Rachel Kuchtey, MD, PhD

By Section editor Tony Realini, MD, MPH

LANDMARK STUDIES

Costs and Financial Gain Associated With Glaucoma Therapy

Ophthalmic interventions deliver significant patient and financial value.

By Gary C. Brown, MD, MBA; Melissa M. Brown, MD, MN, MBA; Joshua D. Stein, MD, MSc, MS; Richard P. Wilson, MD; and George L. Spaeth, MD

SURGICAL PEARLS

ICE Combination Therapy

This procedure allows my patients with early glaucoma to benefit from refractive cataract surgery and a reduction of the burden of medication.

By Steven R. Sarkisian Jr, MD

COVER STORIES: THE NEW FACE OF THE GLAUCOMA DOCTOR

Glaucoma and Primary Care

We are treating the whole patient, not just his or her eyes.

By Jody Piltz-Seymour, MD

The Optometrist’s Role in Glaucoma Care

Involvement varies among providers for several reasons.

By Murray Fingeret, OD

Does the Integrated MD-OD Model Represent the Future?

Greater collaboration between these eye care specialists will have a growing role in the management of glaucoma patients.

By Anup K. Khatana, MD

The Evolving Role of Lens Extraction in Glaucoma Care

Cataract surgery lowers the IOP in eyes with many types of glaucoma.

By Marcos Reyes, MD

Laser Cataract Surgery in the Glaucoma Population

These patients present unique considerations and challenges, but many of them can benefit from the use of a femtosecond laser.

By Robert J. Noecker, MD, MBA

IOL Selection Considerations in Glaucoma Patients

Options vary with the severity of the disease.

By Norm Zabriskie, MD

Keratorefractive Surgery in Glaucoma Patients

Considerations for refractive and glaucoma surgeons.

By John P. Berdahl, MD

Perspectives on Tertiary Care Glaucoma

Leveraging technology to strengthen collaborative care.

By Kelly W. Muir, MD

THERAPEUTICS UPDATE

Medical Marijuana for Glaucoma Therapy

Despite the drug’s potential IOP-lowering capabilities, toxicity to the ocular surface is a major concern.

By Katherine Shen, OD

PRACTICE POINTERS

Compassionate Communication

Strategies for building relationships with newly diagnosed patients and those with progressing glaucoma.

By Henry D. Jampel, MD, MHS; Richard J. Madonna, OD; Steven L. Mansberger, MD, MPH; Igor Estrovich, MD; Leo Semes, OD; Julia Song, MD; and Joseph Sowka, OD

5 Questions With Haiyan Gong, MD, PhD

Dr. Gong discusses aqueous outflow and her culinary style.

 

Contact Info

Bryn Mawr Communications LLC
1008 Upper Gulph Road, Suite 200
Wayne, PA 19087

Phone: 484-581-1800
Fax: 484-581-1818

About Glaucoma Today

Glaucoma Today is mailed bimonthly (six times a year) to 11,519 glaucoma specialists, general ophthalmologists, and clinical optometrists who treat patients with glaucoma. Glaucoma Today delivers important information on recent research, surgical techniques, clinical strategies, and technology.